Amlodipine (Norvasc)
ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.
Amlodipine (Norvasc)
ATI class: Calcium channel blocker / Dihydropyridine
Action
- ATI/source-folder candidate for Amlodipine (Norvasc); verify mechanism against the source table before validation.
Therapeutic use
- Review under Hypertension medication safety.
Nursing assessment
- Monitor blood pressure, edema, dizziness, and chest pain response.
- Assess for peripheral edema and weight changes.
- Check medication profile for other antihypertensives and grapefruit-related teaching needs.
Administration
- Verify route against the order and source table.
Side effects
- Verify common side effects against the source table.
Adverse effects
- Peripheral edema
- Hypotension
- Dizziness
- Flushing
- Reflex tachycardia
Interactions
- Other antihypertensives
- Grapefruit products
- CYP3A4 inhibitors
- Simvastatin dose concerns
Contraindications
- See source-specific contraindications and precautions before administration.
Precautions
- Use caution with severe hypotension, severe aortic stenosis, hepatic impairment, and heart failure monitoring needs.
- Peripheral edema can occur even when heart failure is not the cause, but dyspnea or rapid weight gain needs evaluation.
Client teaching
- Change positions slowly.
- Report swelling, severe dizziness, chest pain, or shortness of breath.
- Do not stop antihypertensive therapy without provider direction.
Medication outcomes
- Therapeutic response with no priority adverse effects.
Antidote / rescue
- No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.
NCLEX priority cues
- Syncope or severe hypotension after dosing is priority.
- Leg edema is common, but edema plus dyspnea changes priority.
- Do not confuse routine flushing with unrelieved chest pain.
Medication classes
Source attribution
Related study cards
Shows the medication class, ATI cues, source references, and connected study cards for this drug.
Relaxes vascular smooth muscle and, for selected agents, slows AV node conduction.
ATI medication nursing assessment concept.
ATI medication mechanism of action concept.
ATI medication class concept.
ATI medication client teaching concept.
ATI medication nursing assessment concept.
ATI medication interaction concept.
ATI medication class concept.
ATI medication adverse effect concept.
ATI medication nclex priority cue concept.
ATI medication client teaching concept.
ATI medication adverse effect concept.